Testicular cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Line 39: | Line 39: | ||
| style="background: #F5F5F5; padding: 5px;" |Late metastasis | | style="background: #F5F5F5; padding: 5px;" |Late metastasis | ||
| style="background: #F5F5F5; padding: 5px;" |Stains positively for ALP, c-KIT, CD30, EMA, and glycogen | | style="background: #F5F5F5; padding: 5px;" |Stains positively for ALP, c-KIT, CD30, EMA, and glycogen | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
* Large cells wit watery cytoplasm | * Large cells wit watery cytoplasm | ||
* Fried egg appearance | * Fried egg appearance | ||
Line 63: | Line 63: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 77: | Line 77: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 105: | Line 105: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 119: | Line 119: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metastasis | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Metastasis | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Genetics | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Genetics | ||
! | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass | ||
Line 134: | Line 134: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 148: | Line 148: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 162: | Line 162: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 176: | Line 176: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 15:46, 23 January 2019
Testicular cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Testicular cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Testicular cancer differential diagnosis |
Risk calculators and risk factors for Testicular cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.
Differentiating Testicular cancer from other Diseases
Testicular cancer must be differentiated from:
Diseases | Benign/ Malignant | Unilateral/Bilateral | History | Demography | Metastasis | Genetics | Histopathology | Clinical manifestations | Para-clinical findings | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pain | Mass | Physical examination | |||||||||||
Lab Findings | Imaging | ||||||||||||
Germ Cell | Seminoma[1][2] | Malignant | Unilateral | History of cryptorchidism
Excellent prognosis |
|
Late metastasis | Stains positively for ALP, c-KIT, CD30, EMA, and glycogen |
|
- | + |
|
Elevated serum placental ALP (PALP) | Ultrasound:
Homogeneous hypoechoic intratesticular mass Cysts and calcificications are uncommon Inhomogenous feature in larger mass |
Embryonal carcinoma | |||||||||||||
Yolk sac tumor | |||||||||||||
Teratoma | |||||||||||||
Choriocarcinoma | |||||||||||||
Diseases | Benign/ Malignant | Unilateral/Bilateral | History | Demography | Metastasis | Genetics | Histopathology | Pain | Mass | Physical exam | Lab Findings | Imaging | |
Non germ cell | Leydig cell tumor | ||||||||||||
Sertoli cell tumor | |||||||||||||
Testicular lymphoma | |||||||||||||
Carcinoma in situ of the testicle |
References
- ↑ Siegel RL, Miller KD, Jemal A (2016). "Cancer statistics, 2016". CA Cancer J Clin. 66 (1): 7–30. doi:10.3322/caac.21332. PMID 26742998.
- ↑ Miller FH, Whitney WS, Fitzgerald SW, Miller EI (1999). "Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration". AJR Am J Roentgenol. 172 (2): 425–8. doi:10.2214/ajr.172.2.9930796. PMID 9930796.